Who are Greenwich LifeSciences, Inc.'s main suppliers?

Greenwich LifeSciences, Inc. (GLSI) key suppliers include: HJF, THIRD-PARTY-CONTRACT-MANUFACTURERS, AstraZeneca PLC, AstraZeneca PLC, Gilead Sciences, Inc. and 5 more. View the full supplier network at chainsifter.com/chain/GLSI.

What sector is Greenwich LifeSciences, Inc. in?

Greenwich LifeSciences, Inc. (GLSI) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

GLSI Supply Chain: Greenwich LifeSciences, Inc. Supplier List & 11 Relationships

10Suppliers

0Customers

1Debt Items

20Related Chains

Greenwich LifeSciences, Inc. Suppliers

Ticker	Name	Confidence	Evidence
HJF	HJF	90%	We currently are dependent on a license from HJF for technologies relating to our product candidate.
THIRD-PARTY-CONTRACT-MANUFACTURERS	THIRD-PARTY-CONTRACT-MANUFACTURERS	90%	The Company currently depends on third-party contract manufacturers for all required raw materials, active pharmaceutical ingredients, and finished product candidate for the Company’s clinical trials.
AZN	AstraZeneca PLC	72%	duct candidate and the average exposure time in the clinical development program may be inadequate to detect rare adverse events or chance findings that may only be detected once the product is admin…
AZN	AstraZeneca PLC	72%	Reciprocal relationship from AZN graph: Reciprocal relationship from GLSI graph: duct candidate and the average exposure time in the clinical development program may be inadequate to detect rare adve…
GILD	Gilead Sciences, Inc.	72%	Reciprocal relationship from GILD graph: Reciprocal relationship from GLSI graph: duct candidate and the average exposure time in the clinical development program may be inadequate to detect rare adv…
GILD	Gilead Sciences, Inc.	72%	duct candidate and the average exposure time in the clinical development program may be inadequate to detect rare adverse events or chance findings that may only be detected once the product is admin…
JNJ	Johnson & Johnson	72%	duct candidate and the average exposure time in the clinical development program may be inadequate to detect rare adverse events or chance findings that may only be detected once the product is admin…
JNJ	Johnson & Johnson	72%	Reciprocal relationship from JNJ graph: Reciprocal relationship from GLSI graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from GLSI graph: duct candidate and the average exposu…
MRK	Merck & Co., Inc.	72%	duct candidate and the average exposure time in the clinical development program may be inadequate to detect rare adverse events or chance findings that may only be detected once the product is admin…
MRK	Merck & Co., Inc.	72%	Reciprocal relationship from MRK graph: Reciprocal relationship from GLSI graph: Reciprocal relationship from MRK graph: Reciprocal relationship from GLSI graph: Reciprocal relationship from MRK grap…

Greenwich LifeSciences, Inc. Customers

No clients on recordNo downstream customers found in our database for Greenwich LifeSciences, Inc..

Greenwich LifeSciences, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
GLSI-DEBT-9804	Warrants outstanding: 8012684	90%	xbrl warrant detail from xbrl 2025-09-30.

Greenwich LifeSciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Greenwich LifeSciences, Inc..

Greenwich LifeSciences, Inc. Ownership

Holder	Name	Confidence	Evidence
GLSI-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 64 tracked holders.

Greenwich LifeSciences, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
JNJ	Johnson & Johnson	100.00	1	['supplier']
MRK	Merck & Co., Inc.	100.00	1	['supplier']
GILD	Gilead Sciences, Inc.	100.00	1	['supplier']
AZN	AstraZeneca PLC	100.00	1	['supplier']
CTMX	CytomX Therapeutics, Inc.	50.00	2
CTNM	Contineum Therapeutics, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
AORT	Artivion, Inc.	50.00	2
CYTOF	Altamira Therapeutics Ltd.	50.00	2
AVBP	ArriVent BioPharma, Inc.	50.00	2
CRBP	Corbus Pharmaceuticals Holdings, Inc.	50.00	2
DEO	Diageo plc	50.00	2
BNBX	BNB Plus Corp.	50.00	2
DKS	DICK'S Sporting Goods, Inc.	50.00	2
CYTK	Cytokinetics, Incorporated	50.00	2
EXOZ	eXoZymes, Inc.	50.00	2
IMMP	Immutep Limited	50.00	2
CBIH	Cannabis Bioscience International Holdings, Inc.	50.00	2
BNR	Burning Rock Biotech Limited	50.00	2
AVIR	Atea Pharmaceuticals, Inc.	50.00	2

Greenwich LifeSciences, Inc. Supply Chain